# Skyward Specialty Insurance Group, Inc.: financial statements, quarterly

SKWD · Nasdaq · CIK 1519449 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/skwd.md) · [Financials](/companies/skwd/financials.md) · [Filings](/companies/skwd/filings.md) · [Insiders](/companies/skwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.1](/filings/0001519449-24-000047.md) | [4.0 d](/filings/0001519449-26-000015.md) | [2.0](/filings/0001519449-25-000023.md) | [2.1](/filings/0001519449-25-000040.md) | [1.8](/filings/0001519449-25-000061.md) | [4.8 d](/filings/0001519449-26-000015.md) | [3.0](/filings/0001519449-26-000039.md) | [4.1](/filings/0001519449-26-000054.md) | [1.9](/filings/0001519449-25-000061.md) | [5.9 d](/filings/0001519449-26-000015.md) | [3.3](/filings/0001519449-26-000039.md) | [4.6](/filings/0001519449-26-000054.md) |
| Interest expense | $m | [2.6](/filings/0001519449-24-000047.md) | [2.8 d](/filings/0001519449-26-000015.md) | [2.7](/filings/0001519449-25-000023.md) | [2.4](/filings/0001519449-25-000040.md) | [2.2](/filings/0001519449-25-000061.md) | [2.1 d](/filings/0001519449-26-000015.md) | [1.8](/filings/0001519449-26-000039.md) | [1.9](/filings/0001519449-26-000054.md) | [1.9](/filings/0001519449-25-000061.md) | [2.3 d](/filings/0001519449-26-000015.md) | [7.7](/filings/0001519449-26-000039.md) | [8.8](/filings/0001519449-26-000054.md) |
| Income tax | $m | [6.1](/filings/0001519449-24-000047.md) | [8.3 d](/filings/0001519449-26-000015.md) | [10.2](/filings/0001519449-25-000023.md) | [9.4](/filings/0001519449-25-000040.md) | [10.2](/filings/0001519449-25-000061.md) | [4.1 d](/filings/0001519449-26-000015.md) | [9.4](/filings/0001519449-26-000039.md) | [11.0](/filings/0001519449-26-000054.md) | [14.6](/filings/0001519449-25-000061.md) | [11.4 d](/filings/0001519449-26-000015.md) | [12.3](/filings/0001519449-26-000039.md) | [14.5](/filings/0001519449-26-000054.md) |
| Net income | $m | [21.7](/filings/0001519449-24-000047.md) | [29.3 d](/filings/0001519449-26-000015.md) | [36.8](/filings/0001519449-25-000023.md) | [31.0](/filings/0001519449-25-000040.md) | [36.7](/filings/0001519449-25-000061.md) | [14.4 d](/filings/0001519449-26-000015.md) | [42.1](/filings/0001519449-26-000039.md) | [38.8](/filings/0001519449-26-000054.md) | [45.9](/filings/0001519449-25-000061.md) | [43.2 d](/filings/0001519449-26-000015.md) | [49.7](/filings/0001519449-26-000039.md) | [49.0](/filings/0001519449-26-000054.md) |
| Diluted EPS | $ per share | [0.57](/filings/0001519449-24-000047.md) | not reported | [0.90](/filings/0001519449-25-000023.md) | [0.75](/filings/0001519449-25-000040.md) | [0.89](/filings/0001519449-25-000061.md) | not reported | [1.01](/filings/0001519449-26-000039.md) | [0.93](/filings/0001519449-26-000054.md) | [1.10](/filings/0001519449-25-000061.md) | not reported | [1.09](/filings/0001519449-26-000039.md) | [1.07](/filings/0001519449-26-000054.md) |
| Basic EPS | $ per share | [0.59](/filings/0001519449-24-000047.md) | not reported | [0.94](/filings/0001519449-25-000023.md) | [0.79](/filings/0001519449-25-000040.md) | [0.91](/filings/0001519449-25-000061.md) | not reported | [1.05](/filings/0001519449-26-000039.md) | [0.96](/filings/0001519449-26-000054.md) | [1.13](/filings/0001519449-25-000061.md) | not reported | [1.12](/filings/0001519449-26-000039.md) | [1.10](/filings/0001519449-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [53.7](/filings/0001519449-23-000039.md) | [65.9](/filings/0001519449-25-000047.md) | [85.1](/filings/0001519449-24-000024.md) | [73.0](/filings/0001519449-24-000035.md) | [106](/filings/0001519449-24-000047.md) | [122](/filings/0001519449-26-000015.md) | [113](/filings/0001519449-25-000023.md) | [137](/filings/0001519449-25-000040.md) | [160](/filings/0001519449-25-000061.md) | [169](/filings/0001519449-26-000054.md) | [256](/filings/0001519449-26-000039.md) | [219](/filings/0001519449-26-000054.md) |
| Total assets | $m | [2,851](/filings/0001519449-23-000039.md) | [2,953](/filings/0001519449-25-000047.md) | [3,187](/filings/0001519449-24-000024.md) | [3,435](/filings/0001519449-24-000035.md) | [3,599](/filings/0001519449-24-000047.md) | [3,729](/filings/0001519449-26-000015.md) | [4,031](/filings/0001519449-25-000023.md) | [4,336](/filings/0001519449-25-000040.md) | [4,594](/filings/0001519449-25-000061.md) | [4,792](/filings/0001519449-26-000054.md) | [6,547](/filings/0001519449-26-000039.md) | [6,781](/filings/0001519449-26-000054.md) |
| Total liabilities | $m | [2,315](/filings/0001519449-23-000039.md) | [2,292](/filings/0001519449-25-000047.md) | [2,495](/filings/0001519449-24-000024.md) | [2,712](/filings/0001519449-24-000035.md) | [2,801](/filings/0001519449-24-000047.md) | [2,935](/filings/0001519449-26-000015.md) | [3,180](/filings/0001519449-25-000023.md) | [3,436](/filings/0001519449-25-000040.md) | [3,633](/filings/0001519449-25-000061.md) | [3,782](/filings/0001519449-26-000054.md) | [5,323](/filings/0001519449-26-000039.md) | [5,514](/filings/0001519449-26-000054.md) |
| Shareholders' equity | $m | [535](/filings/0001519449-24-000047.md) | [661](/filings/0001519449-26-000015.md) | [692](/filings/0001519449-25-000023.md) | [724](/filings/0001519449-25-000040.md) | [798](/filings/0001519449-25-000061.md) | [794](/filings/0001519449-26-000015.md) | [851](/filings/0001519449-26-000039.md) | [900](/filings/0001519449-26-000054.md) | [961](/filings/0001519449-25-000061.md) | [1,010](/filings/0001519449-26-000054.md) | [1,225](/filings/0001519449-26-000039.md) | [1,268](/filings/0001519449-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [110 d](/filings/0001519449-24-000047.md) | [120 d](/filings/0001519449-26-000015.md) | [94.3](/filings/0001519449-25-000023.md) | [21.0 d](/filings/0001519449-25-000040.md) | [168 d](/filings/0001519449-25-000061.md) | [21.9 d](/filings/0001519449-26-000015.md) | [96.8](/filings/0001519449-26-000039.md) | [88.2 d](/filings/0001519449-26-000054.md) | [171 d](/filings/0001519449-25-000061.md) | [51.8 d](/filings/0001519449-26-000015.md) | [117](/filings/0001519449-26-000039.md) | [67.6 d](/filings/0001519449-26-000054.md) |
| Capital expenditure | $m | [(1.2) d](/filings/0001519449-24-000047.md) | [3.1 d](/filings/0001519449-26-000015.md) | [0.3](/filings/0001519449-25-000023.md) | [2.5 d](/filings/0001519449-25-000040.md) | [0.4 d](/filings/0001519449-25-000061.md) | [1.1 d](/filings/0001519449-26-000015.md) | [0.2](/filings/0001519449-25-000023.md) | [1.1 d](/filings/0001519449-26-000054.md) | [2.5 d](/filings/0001519449-25-000061.md) | [1.7 d](/filings/0001519449-26-000015.md) | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001519449-26-000039.md) | [0.0 d](/filings/0001519449-26-000054.md) | not reported | not reported | [8.7](/filings/0001519449-26-000039.md) | [10.8 d](/filings/0001519449-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.5](/filings/0001519449-23-000039.md) | [37.0](/filings/0001519449-24-000024.md) | [38.1](/filings/0001519449-24-000035.md) | [38.4](/filings/0001519449-24-000047.md) | [41.1](/filings/0001519449-25-000023.md) | [41.2](/filings/0001519449-25-000040.md) | [41.4](/filings/0001519449-25-000061.md) | [41.7](/filings/0001519449-26-000039.md) | [41.9](/filings/0001519449-26-000054.md) | [41.9](/filings/0001519449-25-000061.md) | [45.4](/filings/0001519449-26-000039.md) | [45.7](/filings/0001519449-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 44,396,493 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001519449-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.